News

Finding a global regulatory GPS of ethics committee and competent authority approvals.

The European Parliament's Pediatric Regulation has seen its first approval for a centrally authorized drug to be used in children.

PPD, Inc. today announced the Mario Family Foundation has pledged $5 million to the Rutgers University Ernest Mario School of Pharmacy.

ECRFPlus achieves milestone multimillion dollar enterprise agreement with CRO and launches e-CRF+(TM): a CTMS and EDC Web platform with ECG analysis and cardiac safety module.

TAKE Solutions' Life Sciences division announced today the release of PharmaReady Version 4.1 that offers new enhancements to the fully integrated, Web-based suite of products.

Health officials/patient advocates link underrepresentation of minorities in clinical trials with higher death rates.

Medidata Solutions, a provider of clinical trial solutions, today announced the launch of Medidata Developer Central, a Web-based community that supports developers? efforts to integrate their clinical trial solutions with Medidata Rave, an electronic data capture (EDC), clinical data management (CDM), and reporting system.

Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today that it has been awarded a contract from the National Institutes of Child Health and Human Development (NICHD) to provide clinical trial management services for a study to be conducted by the Division of Epidemiology, Statistics and Prevention Research (DESPR).

Opinions on paediatric investigation plans.

Epistem plc, a UK biotechnology and contract research company, will present results from their latest plucked hair biomarker study at the ASCO-NCI-EORTC Meeting on Molecular Markers in Cancer, Hollywood FL, United States on Friday 31st October 2008.

New director appointed to the Office for Human Research Protections (OHRP).

PRA International, a Clinical Research Organization, announced today the appointment of Dr. Jerome Wilson as Senior Medical Director of Late Phase Services.

Rare disease patients, academic researchers, NGOs and industry united their voices in a call to EU governments to take action this Autumn to address the issues facing patients affected by rare diseases in Europe.

Qualia Clinical Services, a division of Holmes Biopharma, selects ALPHADAS, Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.

Qualia Clinical Services, a division of Holmes Biopharma, selects ALPHADAS, Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.

PPD, Inc. has reported its financial and operating results for the third quarter ended September 30, 2008.

iCardiac announced today that it has completed a highly automated analysis of ECG data for a leading pharmaceutical firm?s Thorough QT (TQT) study.

Pharsight Corporation, a provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that is has initiated beta testing of its new Phoenix analysis and modeling software platform.

Perceptive Informatics, an eClinical technology provider and a subsidiary of PAREXEL International Corporation, announced the release of an enhanced version of its award-winning DataLabs Electronic Data Capture (EDC) and Clinical Data Management System (CDMS) solution to improve the efficiency and data quality of clinical studies.

New simulator to help refine animal testing and streamline pharmaceutical research.

ICON reports 35% increase in revenue and 45% increase in operating income.

SGS Leverages Phase Forward's InForm and Central Designer Solutions for Greater Clinical Trial Efficiencies

SGS Leverages Phase Forward's InForm and Central Designer Solutions for Greater Clinical Trial Efficiencies

Aris Global's Release of agXchange SIR Enables Trial Sponsors to Automate Investigator Safety Reporting and Reap Significant Cost Savings

ProTrials Research, Inc., today announced that it has been selected as a finalist for the 5th annual Stevie Awards for Women in Business.

First-cycle approval for NME produces $640 million in incremental revenue on average.